SWC
IDXX icon

Spectrum Wealth Counsel’s Idexx Laboratories IDXX Stock Holding History

Spectrum Wealth Counsel’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-83
Closed -$44.8K – 397
2024
Q1 		$44.8K Sell
83
-3
-3% -$1.64K 0.01% 216
2023
Q4 		$47.7K Buy
+86
New +$40.4K 0.01% 196

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Spectrum Wealth Counsel's IDXX Position: Q2 2024 in Review

Spectrum Wealth Counsel sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 83 shares — an estimated $44.8K sold.

Spectrum Wealth Counsel first reported a position in IDXX in Q4 2023 and held it in 2 quarters. The position peaked at $47.7K in Q4 2023. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Spectrum Wealth Counsel reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • Spectrum Wealth Counsel sold 83 Idexx Laboratories shares in Q2 2024, an estimated $44.8K.
  • Spectrum Wealth Counsel first reported a position in Idexx Laboratories in Q4 2023 and held it in 2 quarters.
  • Spectrum Wealth Counsel's Idexx Laboratories position peaked at $47.7K in Q4 2023.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Spectrum Wealth Counsel's 13F filing for Q2 2024, filed 8 Aug 2024.